Assembly Biosciences, Inc. (ASMB)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-19) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-20) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-08) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-28) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-08) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-09) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Operations and Comprehensive Loss (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Cash Flows (P) | ||
| Notes | ||
| Collaboration Agreements | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Employee Benefit Plan | — |
|
| Fair Value Measurements and Investments In Marketable Securities | — |
|
| Hbv Research Agreement With Indiana University | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Investments In Marketable Securities | — |
|
| Leases | ||
| Milestones and Research Agreements | — |
|
| Nature of Business | ||
| Operating Leases | — |
|
| Other Accrued Expenses | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Related Party | ||
| Restructurings | ||
| Sale of Common Stock | — |
|
| Sale of Common Stock and Warrants | — |
|
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders' Equity | ||
| Strategic License Agreements | — |
|
| Subsequent Event | ||
| Summary of Significant Accounting Policies | — |
|
| Summary of Significant Accounting Policies and Recent Accounting Pronouncements | — |
|